Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 25, 2022

SELL
$25.33 - $34.25 $162,719 - $220,022
-6,424 Closed
0 $0
Q1 2022

Apr 28, 2022

BUY
$28.51 - $32.9 $183,148 - $211,349
6,424 New
6,424 $208,000

Others Institutions Holding SUPN

About SUPERNUS PHARMACEUTICALS, INC.


  • Ticker SUPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,495,300
  • Market Cap $1.9B
  • Description
  • Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...
More about SUPN
Track This Portfolio

Track Euclidean Technologies Management, LLC Portfolio

Follow Euclidean Technologies Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Euclidean Technologies Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Euclidean Technologies Management, LLC with notifications on news.